The Asian Scientist 100
Lu Ke
Institution
Chinese Academy of Sciences
Country
China
Field
Materials Sciences
Lu is the winner of the 2020 Future Science Prize (Physical Science Prize) for discovering and synthesizing a superior nanotwinned structure and gradient nanostructure.
(Photo: Future Science Prize)
AWARDS
- Future Science Prize 2020
Related articles
Stop Peeing In Pools, Scientists Say
Not only is peeing in the swimming pool antisocial, it could also harm your health, according to a study.
Diabetic Women Face Higher Risk Of Stroke Than Men
A meta-analysis of papers published on diabetes shows that diabetic women are more susceptible to stroke than diabetic men, possibly because of obesity.
Singaporean Scientists: Haze Also Harms The Oceans
Although many people are rightly concerned about the effects of haze on the land and air quality, scientists say that its impact on the marine environment also deserves attention and intervention.
Yoga Lowers Stress Hormones In Breast Cancer Patients, Study
Breast cancer patients who practiced yoga not only had general better health and regulation of cortisol levels but were also more able to find meaning in their illness, a study reports.
Study Shows Community-Based Care For Schizophrenia Works
Community intervention was found to be more effective at reducing symptoms and disabilities in schizophrenics compared to facility-based care.
A Bird’s Eye View Of Flowers
Mathematical models show that a disproportionate number of Australian flowers have colors that attract honeyeaters, suggesting that flowers have evolved in response to bird visual systems.
China, UK Pledge US$33 Million For Climate Change Program
Building on five years of partnership, China and the UK have committed US$33 million to research in low carbon solutions.
Protein To Carbohydrate Ratio Outweighs Calorie Counting
A study shows that for metabolic health, it is the ratio of protein to carbohydrates in the diet that matters more than the total number of calories consumed.
Shanxi Taxus, Cardium Therapeutics Enter Partnership
China's Shanxi Taxus' investment in US firm Cardium Therapeutics for the development of two new drugs will also give both companies access to each others' home markets.